Ardelyx, Inc. (ARDX)
3.085
-0.04
(-1.12%)
USD |
NASDAQ |
Nov 13, 16:00
3.085
0.00 (0.00%)
After-Hours: 19:59
Ardelyx Enterprise Value : 754.22M for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 754.22M |
| November 11, 2026 | 756.73M |
| November 10, 2026 | 726.60M |
| November 09, 2026 | 706.52M |
| November 06, 2026 | 693.97M |
| November 05, 2026 | 721.58M |
| November 04, 2026 | 796.89M |
| November 03, 2026 | 731.62M |
| November 02, 2026 | 731.62M |
| October 30, 2026 | 731.62M |
| October 29, 2026 | 749.20M |
| October 28, 2026 | 749.20M |
| October 27, 2026 | 724.09M |
| October 26, 2026 | 724.09M |
| October 23, 2026 | 744.18M |
| October 22, 2026 | 774.30M |
| October 21, 2026 | 756.73M |
| October 20, 2026 | 776.81M |
| October 19, 2026 | 746.69M |
| October 16, 2026 | 746.69M |
| October 15, 2026 | 791.87M |
| October 14, 2026 | 771.79M |
| October 13, 2026 | 754.22M |
| October 12, 2026 | 781.83M |
| October 09, 2026 | 794.38M |
| Date | Value |
|---|---|
| October 08, 2026 | 791.87M |
| October 07, 2026 | 789.36M |
| October 06, 2026 | 801.91M |
| October 05, 2026 | 822.00M |
| October 02, 2026 | 809.44M |
| October 01, 2026 | 819.49M |
| September 30, 2026 | 829.53M |
| September 29, 2026 | 818.97M |
| September 28, 2026 | 823.95M |
| September 25, 2026 | 826.44M |
| September 24, 2026 | 833.92M |
| September 23, 2026 | 841.39M |
| September 22, 2026 | 876.27M |
| September 21, 2026 | 846.37M |
| September 18, 2026 | 826.44M |
| September 17, 2026 | 816.48M |
| September 16, 2026 | 818.97M |
| September 15, 2026 | 821.46M |
| September 14, 2026 | 851.36M |
| September 11, 2026 | 866.31M |
| September 10, 2026 | 876.27M |
| September 09, 2026 | 921.12M |
| September 08, 2026 | 913.64M |
| September 04, 2026 | 916.14M |
| September 03, 2026 | 898.70M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Capricor Therapeutics, Inc. | 489.99M |
| Mirum Pharmaceuticals, Inc. | 6.456B |
| Compass Therapeutics, Inc. | -6.152M |
| ARS Pharmaceuticals, Inc. | 365.40M |
| Sionna Therapeutics, Inc. | -61.75M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.737M |
| Revenue (Quarterly) | 127.66M |
| Total Expenses (Quarterly) | 128.39M |
| EPS Diluted (Quarterly) | -0.003 |
| Gross Profit Margin (Quarterly) | 95.96% |
| Profit Margin (Quarterly) | -0.58% |
| Earnings Yield | -7.30% |
| Normalized Earnings Yield | -7.293 |